We are live on
!
Find out more
GG
Gofen & Glossberg Portfolio holdings
AUM
$3.89B
1-Year Est. Return
11.97%
This Fund
S&P 500
This Quarter
Est. Return
+1.81%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
–
Cap. Flow
+$1.86B
Cap. Flow
% of AUM
100.71%
Top 10 Holdings %
Top 10 Hldgs %
26.1%
Holding
499
New
498
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$73.6M |
| 2 |
Procter & Gamble
PG
|
+$65.5M |
| 3 |
ExxonMobil
XOM
|
+$59.2M |
| 4 |
Johnson & Johnson
JNJ
|
+$50.5M |
| 5 |
JPMorgan Chase
JPM
|
+$43M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.65% |
| 2 | Consumer Staples | 12.01% |
| 3 | Technology | 11.7% |
| 4 | Industrials | 11.32% |
| 5 | Financials | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Target
TGT
$62.1B
| $16.5M | 0.9% |
+240,284
| New | +$16.7M |
|
27
Caterpillar
CAT
$409B
| $16.5M | 0.9% |
+200,425
| New | +$17M |
|
28
Vodafone
VOD
$34.9B
| $16.4M | 0.89% |
+560,698
| New | +$16.7M |
|
29
Ecolab
ECL
$75.6B
| $16.3M | 0.89% |
+191,798
| New | +$16.2M |
|
|
EMC
30
DELISTED
EMC CORPORATION
EMC
| $16.2M | 0.88% |
+687,423
| New | +$16.2M |
|
31
Alphabet (Google) Class C
GOOG
$3.9T
| $16M | 0.87% |
+730,889
| New | +$15.5M |
|
32
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $15.4M | 0.83% |
+95,899
| New | +$15.4M |
|
33
iShares MSCI Emerging Markets ETF
EEM
$28B
| $15.3M | 0.83% |
+396,972
| New | +$16.5M |
|
34
Boeing
BA
$165B
| $15M | 0.81% |
+145,971
| New | +$13.9M |
|
35
National Grid
NGG
$82.7B
| $14.8M | 0.8% |
+271,269
| New | +$15.8M |
|
36
Gilead Sciences
GILD
$161B
| $14.6M | 0.79% |
+284,095
| New | +$14.8M |
|
37
Apple
AAPL
$4.89T
| $14.1M | 0.76% |
+996,184
| New | +$15.3M |
|
|
DD
38
DELISTED
Du Pont De Nemours E I
DD
| $14M | 0.76% |
+281,089
| New | +$14.2M |
|
39
Berkshire Hathaway Class B
BRK.B
$1.07T
| $13.9M | 0.75% |
+124,030
| New | +$13.6M |
|
|
UN
40
DELISTED
Unilever NV New York Registry Shares
UN
| $13.6M | 0.74% |
+345,835
| New | +$14.2M |
|
41
Philip Morris
PM
$301B
| $13.2M | 0.72% |
+152,570
| New | +$14.2M |
|
42
3M
MMM
$89B
| $13M | 0.7% |
+142,275
| New | +$12.9M |
|
43
Teva Pharmaceuticals
TEVA
$35.9B
| $12.8M | 0.69% |
+327,221
| New | +$12.7M |
|
44
Merck
MRK
$324B
| $12.8M | 0.69% |
+288,344
| New | +$12.9M |
|
45
Pfizer
PFE
$140B
| $12.5M | 0.68% |
+470,159
| New | +$13M |
|
46
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $12.2M | 0.66% |
+313,683
| New | +$13.2M |
|
47
McCormick & Company Non-Voting
MKC
$13.4B
| $12.1M | 0.66% |
+344,872
| New | +$12.4M |
|
48
iShares MSCI EAFE ETF
EFA
$76.4B
| $12M | 0.65% |
+210,026
| New | +$12.7M |
|
49
AbbVie
ABBV
$458B
| $11.6M | 0.63% |
+281,266
| New | +$12.3M |
|
50
Truist Financial
TFC
$63.2B
| $10.9M | 0.59% |
+321,739
| New | +$10.3M |
|
Similar funds
AIM
AAM
ZCA
GJIC
SBL
RCAMU
TFS
S
Gofen & Glossberg's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Gofen & Glossberg, which disclosed 499 positions worth $1.85B. Its ten largest holdings account for 26% of the portfolio.
Its largest position is IBM: 378,070 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Consumer Staples and Technology.
- Gofen & Glossberg's largest Q2 2013 buy was IBM: 378,070 shares worth $69.1M.
- Gofen & Glossberg's ten largest holdings make up 26% of its $1.85B portfolio in Q2 2013.
- Gofen & Glossberg disclosed 499 positions in Q2 2013, its first 13F filing on record.
Based on Gofen & Glossberg's 13F filing for Q2 2013, filed 17 Jul 2013.